ScinoPharm Taiwan Ltd banner

ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 19.1 TWD 1.06%
Market Cap: NT$15.1B

Intrinsic Value

The intrinsic value for ScinoPharm Taiwan Ltd (1789) under the Base Case is 16.63 TWD. Compared with the current market price of 19.1 TWD, the stock appears Overvalued by 13% .

Intrinsic value calculated as an equal blend of DCF
NT$17.83
and Multiples
NT$15.43
Other reference points

Do our valuations actually work? See backtest results .

Intrinsic Value
NT$16.63
Overvaluation 13%
Intrinsic Value
Price NT$19.1
Monitor ScinoPharm Taiwan Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value NT$13.3
Get notified when the price drops into your buy zone
Current Price NT$19.1
Intrinsic Value NT$16.63
Margin of Safety 20% NT$13.3
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about ScinoPharm Taiwan Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ScinoPharm Taiwan Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for ScinoPharm Taiwan Ltd.

Explain Valuation
Alternatives to ScinoPharm Taiwan Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one ScinoPharm Taiwan Ltd stock?

The intrinsic value for ScinoPharm Taiwan Ltd (1789) under the Base Case is 16.63 TWD.

Is ScinoPharm Taiwan Ltd stock undervalued or overvalued?

Compared with the current market price of 19.1 TWD, the stock appears Overvalued by 13% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett